uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Yellox
Authorised
Human
Details
EMA number
EMEA/H/C/001198
ATC code
S01BC11
Authorisation
18 May 2011
Revision
13
EMA page
Therapeutic indication
Treatment of postoperative ocular inflammation following cataract extraction in adults.
MeSH:
Pain, Postoperative;Ophthalmologic Surgical Procedures
Group:
Ophthalmologicals
Active substances
bromfenac sodium sesquihydrate
Marketing Authorisation Holder
Bausch + Lomb Ireland Limited
MAH
Timeline
Filter by authority:
EMA
Yellox authorised
18 May 2011
authorised
regulatory
Yellox | uMedical